Seth Lederman
2014
In 2014, Seth Lederman earned a total compensation of $2.9M as Chief Executive Officer at Tonix Pharmaceuticals Holding, a 166% increase compared to previous year.
Compensation breakdown
| Bonus | $170,000 |
|---|---|
| Option Awards | $2,273,980 |
| Salary | $371,875 |
| Other | $37,723 |
| Total | $2,853,578 |
Lederman received $2.3M in option awards, accounting for 80% of the total pay in 2014.
Lederman also received $170K in bonus, $371.9K in salary and $37.7K in other compensation.
Rankings
In 2014, Seth Lederman's compensation ranked 3,191st out of 13,032 executives tracked by ExecPay. In other words, Lederman earned more than 75.5% of executives.
| Classification | Ranking | Percentile |
|---|---|---|
All | 3,191 out of 13,032 | 76th |
Division Manufacturing | 1,134 out of 4,965 | 77th |
Major group Chemicals And Allied Products | 364 out of 1,690 | 79th |
Industry group Drugs | 286 out of 1,369 | 79th |
Industry Pharmaceutical Preparations | 234 out of 1,042 | 78th |
Source: SEC filing on March 25, 2016.
Lederman's colleagues
We found two more compensation records of executives who worked with Seth Lederman at Tonix Pharmaceuticals Holding in 2014.
News
Tonix Pharmaceuticals Holding CEO Seth Lederman's 2023 pay falls 55% to $2.1M
April 15, 2024
Tonix Pharmaceuticals Holding CEO Seth Lederman's 2022 pay falls 41% to $4.6M
March 17, 2023
Tonix Pharmaceuticals Holding CEO Seth Lederman's 2021 pay jumps 99% to $7.7M
March 18, 2022
Tonix Pharmaceuticals Holding CEO Seth Lederman's 2020 pay jumps 201% to $3.9M
March 31, 2021
Tonix Pharmaceuticals Holding CEO Seth Lederman's 2019 pay slips 13% to $1.3M
March 30, 2020
Tonix Pharmaceuticals Holding CEO Seth Lederman's 2018 pay jumps 157% to $1.5M
March 18, 2019